首页/数据集/Crystal structure of SARS-Cov-2 main protease E166N mutant in complex with Leritrelvir

Crystal structure of SARS-Cov-2 main protease E166N mutant in complex with Leritrelvir

NIAID Data Ecosystem2026-05-10 收录

SARS-CoV-2主蛋白酶复合物结构

抗病毒药物设计

数据链接：

https://www.rcsb.org/structure/9MCO 数据链接链接失效反馈

官方服务：

资源简介：

Crystal structure of SARS-Cov-2 main protease E166N mutant in complex with Leritrelvir

应用场景：

创建时间：

2026-03-25

抗病毒药物设计

蛋白质相互作用

Structure-based stabilization of protein–protein interactions (PPIs) is a promising strategy for drug discovery. However, this approach has mainly focused on the stabilization of native PPIs, and non-

NIAID Data Ecosystem60

Crystal structure of SARS-CoV-2 NSP3 Macrodomain in complex with ASAP-0000601-001

病毒蛋白结构解析

抗病毒药物设计

Crystal structure of SARS-CoV-2 NSP3 Macrodomain in complex with ASAP-0000601-001

NIAID Data Ecosystem30

Crystal structure of SARS-CoV-2 main protease A191T mutant in complex with an inhibitor Nirmatrelvir

SARS-CoV-2蛋白

抗病毒药物设计

Crystal structure of SARS-CoV-2 main protease A191T mutant in complex with an inhibitor Nirmatrelvir

NIAID Data Ecosystem20

Crystal Structure of uncleaved SARS-CoV-2 Main Protease C145S mutant in complex with Nirmatrelvir

抗病毒药物设计

蛋白质晶体学

Crystal Structure of uncleaved SARS-CoV-2 Main Protease C145S mutant in complex with Nirmatrelvir Descriptor: (1R,2S,5S)-N-{(1E,2S)-1-imino-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-[3-

Protein Data Bank Japan2024-10-16 更新50

1.55 A resolution structure of SARS-CoV-2 3CL protease in complex with inhibitor 3c

蛋白质结构解析

抗病毒药物设计

1.55 A resolution structure of SARS-CoV-2 3CL protease in complex with inhibitor 3c

NIAID Data Ecosystem30